Curiox Biosystems Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,047,532	299,264	403,531	-	-	-
Market Cap Growth	575.81%	-25.84%	-	-	-	-
Enterprise Value	2,028,950	276,962	383,796	-	-	-
Last Close Price	119600.00	18560.00	25150.00	-	-	-
PS Ratio	480.85	65.23	59.45	-	-	-
PB Ratio	38.09	6.15	7.63	-	-	-
P/TBV Ratio	110.82	23.66	20.93	-	-	-
EV/Sales Ratio	-	60.37	56.54	-	-	-
Debt / Equity Ratio	0.04	0.17	0.02	0.01	1.40	0.46
Net Debt / Equity Ratio	-0.35	-0.41	-0.32	-0.19	0.49	0.16
Net Debt / EBITDA Ratio	1.75	1.86	1.97	0.85	-1.50	-2.01
Net Debt / FCF Ratio	1.79	2.01	2.02	0.78	-1.97	-1.51
Asset Turnover	0.06	0.07	0.13	0.14	0.11	-
Inventory Turnover	1.71	1.19	1.31	1.07	1.72	-
Quick Ratio	2.40	1.45	7.26	3.75	0.66	0.72
Current Ratio	3.01	1.62	7.95	4.92	0.71	0.78
Return on Equity (ROE)	-46.77%	-15.94%	-20.76%	-35.07%	-60.04%	-
Return on Assets (ROA)	-12.14%	-13.03%	-12.40%	-13.67%	-10.72%	-
Return on Capital Employed (ROCE)	-24.00%	-26.40%	-19.20%	-24.90%	-35.50%	-11.40%
Earnings Yield	-1.14%	-2.70%	-2.49%	-	-	-
FCF Yield	-0.51%	-3.33%	-2.08%	-	-	-
Buyback Yield / Dilution	-1.26%	-15.26%	-101.43%	45.55%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.